Bonnie W Lau1, Agnes B Kane. 1. Department of Pathology and Laboratory Medicine, Brown University, Box G-8235, Providence, RI 02912, USA. Bonnie_Lau@brown.edu
Abstract
BACKGROUND/AIM: Tumor progression is influenced by the microenvironment. We found stem cells are recruited to malignant mesothelioma spheroids. We aimed to determine if stem cell recruitment depends on the chemokine SDF1, and if inhibition of the cognate receptor CXCR4 affects tumor growth. MATERIALS AND METHODS: The kinetics of stem cell recruitment was determined using immunofluorescence staining, BrdU incorporation and eGFP transgenic mice. Chemokines were identified using PCR array. Inhibitors of CXCR4 were used to determine the effect on cell migration and tumor progression. RESULTS: The increasing number of stem cells found in tumor spheroids over time is attributed to cell recruitment. Stem cell migration in vitro was enhanced by exogenous SDF1 and abrogated by CXCR4 inhibition and. CXCR4 inhibition reduced tumor burden in vivo. CONCLUSION: SDF1 is a candidate chemokine for recruitment of stem cells to malignant peritoneal mesothelioma and a potential target for therapy.
BACKGROUND/AIM: Tumor progression is influenced by the microenvironment. We found stem cells are recruited to malignant mesothelioma spheroids. We aimed to determine if stem cell recruitment depends on the chemokine SDF1, and if inhibition of the cognate receptor CXCR4 affects tumor growth. MATERIALS AND METHODS: The kinetics of stem cell recruitment was determined using immunofluorescence staining, BrdU incorporation and eGFP transgenic mice. Chemokines were identified using PCR array. Inhibitors of CXCR4 were used to determine the effect on cell migration and tumor progression. RESULTS: The increasing number of stem cells found in tumor spheroids over time is attributed to cell recruitment. Stem cell migration in vitro was enhanced by exogenous SDF1 and abrogated by CXCR4 inhibition and. CXCR4 inhibition reduced tumor burden in vivo. CONCLUSION:SDF1 is a candidate chemokine for recruitment of stem cells to malignant peritoneal mesothelioma and a potential target for therapy.
Authors: Y Shimizu; K Dobashi; H Imai; N Sunaga; A Ono; T Sano; T Hikino; K Shimizu; S Tanaka; T Ishizuka; M Utsugi; M Mori Journal: Int J Immunopathol Pharmacol Date: 2009 Jan-Mar Impact factor: 3.219
Authors: Ruimeng Yang; Chong Duan; Liya Yuan; John A Engelbach; Christina I Tsien; Scott C Beeman; Carlos J Perez-Torres; Xia Ge; Keith M Rich; Joseph J H Ackerman; Joel R Garbow Journal: Int J Radiat Oncol Biol Phys Date: 2017-12-21 Impact factor: 7.038
Authors: Yoshikane Yamauchi; Seyer Safi; Lena Orschiedt; Adriane Gardyan; Stephan Brons; Juliane Rieber; Nils H Nicolay; Peter E Huber; Martin Eichhorn; Hendrik Dienemann; Felix J F Herth; Klaus-Josef Weber; Jürgen Debus; Hans Hoffmann; Stefan Rieken Journal: Oncotarget Date: 2017-07-10